Brain Cancer

Biodexa Pharmaceuticals Launches New Corporate and Clinical Trials Websites Biodexa Pharmaceuticals PLC (NASDAQ: BDRX)…
Read More...

10 July 2023 Biodexa Ltd(“Biodexa” or the “Company”) Completion of Enrolment and Treatment in the Phase 1 Study of…
Read More...

6 July 2023 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Results of Appeal of Delisting Determination…
Read More...

By TARA COPP - Associated Press WASHINGTON (AP) — A Pentagon study has found high…
Read More...

By ZEKE MILLER - AP White House Correspodent WASHINGTON (AP) — A skin lesion…
Read More...

By DARLENE SUPERVILLE - Associated Press WASHINGTON (AP) — A year ago, President…
Read More...

<!-- Name:DistributionId Value:8739359 --> <!--…
Read More...

By DARLENE SUPERVILLE - Associated Press WASHINGTON (AP) — Jill Biden' s advocacy…
Read More...

LOS ANGELES, Oct. 07, 2022 (GLOBE NEWSWIRE) -- InvestorWire -- CNS Pharmaceuticals Inc. (NASDAQ: CNSP), a clinical…
Read More...

AP WASHINGTON (AP) — President Joe Biden next week will highlight his plans for…
Read More...